Crenezumab |
| رقم الكتالوجGC72447 |
Crenezumab (MABT 5102A ؛ RG 7412) هو جسم مضاد لبيتا بيتا أحادي النسل إنساني بالكامل يربط أشكال متعددة من بيتا، مثل قابل للذوبان، قليل النسل، و fibrillar، للاستخدام في أبحاث مرض الزهايمر.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1095207-05-8
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
Crenezumab (MABT 5102A; RG 7412) is a fully humanized anti-Aβ monoclonal antibody that binds multiple forms of Aβ, such as soluble, oligomeric and fibrillar, for use in Alzheimer's disease research.
References:
[1]. S Zampar, et al. N-terminal heterogeneity of parenchymal and vascular amyloid-β deposits in Alzheimer's disease. Neuropathol Appl Neurobiol. 2020 Dec;46(7):673-685.
Review for Crenezumab
Average Rating: 5 (Based on Reviews and 30 reference(s) in Google Scholar.)
Review for Crenezumab
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *